Search

everythinglearnresearchcommunity

for

Search:↓

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Plant-based sensors can help in healthcare but need skilled technicians.

Mealworm protein helps fat cell development and may aid in metabolic health and hair growth.

Neuroregulation is crucial for skin wound healing and can be targeted to improve recovery.

Pomegranate has health benefits and new methods are improving its use in supplements.

Peperomia pellucida is safe to eat and has strong antioxidant benefits.

A temporary capillary cell type helps skin repair after radiation by promoting blood vessel growth.

Long-term anabolic steroid use can lead to heart and metabolic health issues.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

Testosterone may influence COVID-19 severity and outcomes.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 infection can significantly cause temporary hair loss.

Chitosan hydrogels are promising for repairing blood vessels but need improvements in strength and compatibility.

Erythrocyte-anchored nanoparticles improved Cepharanthine delivery and effectiveness for treating acute lung injury.

Minoxidil helps restore thymus size in 22q11.2 deletion syndrome.

Long COVID is a big health problem needing more research and better treatments.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Plantain has potential medicinal benefits but needs more research for safety and effectiveness.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Targeting non-Smad pathways in TGF-β signaling may improve keloid treatment.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Males had more severe COVID-19 symptoms, but their risk of death was only slightly higher than females.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Chitosan-based materials are promising for treating diseases and healing wounds due to their beneficial properties.

Exosome therapy could revolutionize stroke treatment, but more research is needed for human use.

Genetic factors could lead to personalized treatments for hair loss.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.